Virtu Financial LLC Nkarta, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$2.19 - $5.17 $77,968 - $184,062	35,602 New	35,602 $78,000
Q2 2022 Aug 09, 2022	BUY	$7.77 - $19.44 $89,417 - $223,715	11,508 New	11,508 $142,000
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $287,555 - $417,910	-10,782 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$23.94 - $36.68 $258,121 - $395,483	10,782 New	10,782 $342,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.